• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional World ex U.S. Core Equity 2 ETF (NY:DFAX)

29.29 -0.20 (-0.68%)
Official Closing Price Updated: 8:00 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dimensional World ex U.S. Core Equity 2 ETF

Stellantis Just Made A Fresh Appointment To Its North American Design Division: More Details Inside
July 31, 2025
Kruger’s position was newly created, and he will report to CEO Antonio Filosa. 
Via Stocktwits
Topics World Trade
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability
July 30, 2025
Barclays downgraded Novo to ‘Equal Weight’ from ‘Overweight’ with a price target of DKK 375, down from DKK 700. 
Via Stocktwits
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’
July 30, 2025
GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at constant exchange rate. 
Via Stocktwits
Topics Artificial Intelligence World Trade
Novo Nordisk Stock Slumps After Slashing Full-Year Guidance, But Retail Has Its Eyes On An Oral Weight Loss Drug
July 29, 2025
The company now expects full-year sales growth of 8% to 14% at a constant exchange rate, down from its previous estimate of 13% to 21%. 
Via Stocktwits
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence
July 15, 2025
Via Stocktwits
AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React
July 14, 2025
Via Stocktwits
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report
July 11, 2025
Via Stocktwits
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance
July 14, 2025
A decision by the FDA on the new submission is expected in the first half of 2026. 
Via Stocktwits
Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe
July 08, 2025
In addition to the submission to the EMA, Novo Nordisk aims to make the higher dose of Wegovy widely available throughout the European Union. 
Via Stocktwits
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants
July 08, 2025
The company said that it now expects rapid approval for the treatment in eight African countries, including Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, Uganda, and Tanzania. 
Via Stocktwits
Topics Death Government
Stellantis Production In Italy Slumps 27% In H1 2025: Union Now Expects Slump In Annual Numbers
July 07, 2025
The union expects the carmaker to produce 440,000 vehicles across its six assembly plants in Italy this year, including 250,000 passenger cars. 
Via Stocktwits
US Regulator Initiates Recall Query Into Nearly 1.2M Stellantis Ram Trucks: Retail Sentiment Dips
July 07, 2025
NHTSA said that it received 14 vehicle owner questionnaire reports and six death and injury reports under its Early Warning Reporting program describing failures of the Brake Transmission Shift... 
Via Stocktwits
Topics Product Recall
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish
July 03, 2025
Giant cell arteritis (GCA) is the most common form of systemic vasculitis, a group of rare autoimmune diseases characterized by inflammation of blood vessels. 
Via Stocktwits
Stellantis’ US Sales Drop Results In Downgrade At Wolfe, Firm Flags ‘Meaningful Risk’ To 2025, 2026 Earnings
July 02, 2025
Wolfe models about a €1 billion loss in North America this year, versus the consensus call for a roughly €1.6 billion profit, and added that "even this may be optimistic." 
Via Stocktwits
Toyota’s US Sales Rise 7.2% In Q2 Despite A Dull June: Here’s What Drove Demand For The Japanese Carmaker
July 01, 2025
In the three months through the end of June, Toyota Motor reported sales of 666,469 vehicles in the U.S. 
Via Stocktwits
Li Auto Stock Drops Pre-Market After EV Maker Lowers Q2 Delivery Outlook: Retail Remains Bullish
June 27, 2025
Li Auto had previously said that it expects to deliver between 123,000 and 128,000 vehicles in Q2. 
Via Stocktwits
Restaurant Brands Seizes Full Control Of Burger King China In $158M Deal: Retail Stays Bullish
February 18, 2025
The company said its long-term strategy has been to partner with “experienced local operators” while maintaining a primarily franchised business 
Via Stocktwits
Restaurant Brands International Stock In Focus After Q4 Earnings Beat, Burger King Revamp Plan: Retail Cheers
February 13, 2025
For 2025, Restaurant Brands said it plans up to $2.48 in dividends per common share and partnership exchangeable unit of RBI LP 
Via Stocktwits
Topics Earnings
Smirnoff Parent Diageo’s Stock In Spotlight After Company Warns of $200M Impact From Trump Tariffs: Retail’s Extremely Bearish
February 05, 2025
The impact would impact mainly its tequila products, which must be made in Mexico 
Via Stocktwits
Topics Government
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap